Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Al-Sense panty liner device

This article was originally published in The Tan Sheet

Executive Summary

Barr Pharmaceuticals subsidiary Duramed Pharmaceuticals has signed an agreement with Common Sense to develop Al-Sense, a panty liner that detects amniotic fluid. The medical device features a proprietary polymer-coated polyester strip designed to detect amniotic fluid, which could indicate a problem with a pregnancy. The parties are seeking approval of the device in the U.S. and Canada. Although the product would only be available by prescription, other firms have demonstrated an interest in using panty liners as a product delivery form. Fem-V recently announced the launch of its liner, which allows women to test for vaginal infection from their homes by measuring the pH level in vaginal discharge ("1The Tan Sheet" July 3, 2006, p. 10)...

You may also be interested in...

NACDS In Brief

Aleve liqui-gels: Bayer's launch of Aleve liqui-gels demonstrates the growing popularity of the formulation on the market. The product, which contains naproxen sodium 220 mg, will make its marketplace debut in 20-, 40- and 80-count packages in January 2007, the firm announces at the National Association of Chain Drugstores Marketplace conference and tradeshow in San Diego, Calif. June 24-27. A TV and print ad campaign will support the launch, Bayer says. Aleve currently is available in tablets, caplets and gelcaps. Wyeth's Advil liqui-gels saw a 25% sales increased in early 2005, despite concerns about NSAID use (1"The Tan Sheet" July 25, 2005, p. 5)...

Health Sector On High Alert As Wuhan Coronavirus Spreads

The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”

OTC Drug Oversight By US FDA Split Among Two Divisions In Reorganization

CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts